Drugs / MRD-guided therapy
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06157216 | Oct 2023 → Apr 2027 expected | gastric cancer | Qilu Hospital of Shandong University | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MRD-guided therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06157216 ↗ |
| Route | Oral | “S1 (40-60 mg, PO, bid, d1-d14 q3w)” NCT06157216 ↗ |